beyfortus
astrazeneca ab - nirsevimab - immune sera and immunoglobulins, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season.beyfortus should be used in accordance with official recommendations.
beyfortus solution
astrazeneca canada inc - nirsevimab - solution - 50mg - nirsevimab 50mg
beyfortus solution
astrazeneca canada inc - nirsevimab - solution - 100mg - nirsevimab 100mg